• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. DERMABOND PRINEO 22CM SKIN CLOSURE; SURGICAL SEALANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. DERMABOND PRINEO 22CM SKIN CLOSURE; SURGICAL SEALANT Back to Search Results
Catalog Number CLR222US
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hypersensitivity/Allergic reaction (1907); Skin Discoloration (2074); Tissue Damage (2104)
Event Date 06/10/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).The following additional information was requested and received: the information provided indicates that the surgeon attributed the allergy and blister to the prineo dressing.Please explain is there any complaint regarding the stratafix suture? no complaint to stratafix.Incision healed, only complained about redness and blisters from dermabond prineo.Does the surgeon believe that the stratafix caused or contributed to the patient allergic reaction and blistering? no.What was the angle of the knee during application? full flexion of knee.Please describe how was the adhesive applied on the tape adhesive applied on the tape? the polyester mesh of the dermabond prineo skin closure system was first applied to the clean and dry incision at full flexion ensuring the skin on each part of the incision touched each other to ensure full healing.Next the pen applicator containing the 2-octylcyanoacrylate was activated and the entire mesh was covered with the 2-octylcyanoacrylate in a single consistent layer.The mesh was allowed to dry in 90 secs before they cover with mepilex border post-op dressing (10 x 20xm).What prep was used prior to, during or after prineo use? prior to prineo used chlorhexidine, allowed to dry with dry gauze before prineo.After prineo ¿ cover with mepilex border post-op dressing (10 x 20xm) before they compression bandage the knee.Was a dressing placed over the incision? if so, what type of cover dressing used? mepilex border post-op dressing (10 x 20xm).Was the site cultured? if so, what bacteria were identified? no.Is the patient hypersensitive or have allergies to cyanoacrylate or formaldehyde? unknown.Not reported that patient had reported allergies.Is the patient hypersensitive to pressure sensitive adhesives? no.Were any patch or sensitivity tests performed? no.Do you have the lot number of clr222? no.What is the physicians opinion of the contributing factors to the reaction? dermabond prineo caused the allergy.What is the most current patient status? redness went away after 5 days, blisters got better with whole incision hyperpigmented.(b)(6) 2019, friday.Patient demographics: age and gender not sure.Asian and old.Patient pre-existing medical conditions (ie.Allergies, history of reactions) not sure as mentioned above.Was prineo/demabond or skin adhesive used on the patient in a previous surgery or wound closure? no.To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.
 
Event Description
It was reported a patient underwent a total knee replacement procedure on an (b)(6) 2019 and topical skin adhesive was used.Patient had allergy and blistering after using adhesive as closure and wound dressing.The redness and allergy mainly resides along the shape beneath the adhesive dressing.After adhesive dressing was peeled off post-op day (pod) 12 upon patient return to clinic, blisters beneath the mesh were noticed.Surgeon attributed the allergy and blister to the adhesive dressing.Topical steroids were administered.Additional information was requested.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DERMABOND PRINEO 22CM SKIN CLOSURE
Type of Device
SURGICAL SEALANT
Manufacturer (Section D)
ETHICON INC.
p.o. box 151, route 22 west
somerville NJ 08876 0151
Manufacturer (Section G)
ETHICON INC.-SAN LORENZO PR
road 183, km. 8.3
san lorenzo 00754
Manufacturer Contact
darlene kyle
p.o. box 151, route 22 west
somerville, NJ 08876-0151
9082182792
MDR Report Key8772882
MDR Text Key150524230
Report Number2210968-2019-83812
Device Sequence Number1
Product Code OMD
UDI-Device Identifier10705031230996
UDI-Public10705031230996
Combination Product (y/n)N
Reporter Country CodeSN
PMA/PMN Number
K133864
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other
Type of Report Initial
Report Date 06/12/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/09/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberCLR222US
Was Device Available for Evaluation? No
Date Manufacturer Received06/12/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-